Maiva Pharma, a Bengaluru-based injectables manufacturer, has secured ₹1,000 crore in a mix of primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund-IV, led by InvAscent, to set up a new manufacturing plant near Hosur, Tamil Nadu.The fund has acquired a controlling stake with the capital infusion,.
Source: FlipItMoneyAd
Ad